- Revenue 2024
- $3,542,774,981
- Expenses 2024
- $277,559,658
Program services were 38.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
As filed
- Subsection
- 04
- NTEE code
- T99
- Classification
- 3000
- Street
- HELLERUP 2900
These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).
Other organizations at this address
1 other organization in the IRS Business Master File lists the same street address. matched by us
We match the street line and ZIP code as the IRS gives them, ignoring case and outer spaces and nothing else, so "AVE" and "AVENUE" count as different streets and this list can miss some. A shared address can mean related organizations or a shared office, but it can also be a registered agent, a mail drop or a service provider holding mail for unrelated clients. It is not, by itself, evidence that two organizations are connected.
-
NOVO NORDISK FONDEN
EIN 98-1718091
Mission and programs · 2024
Mission
NOVO HOLDINGS A/S (NH) HOLDS AND MANAGES NOVO NORDISK FONDEN'S (NNF) ENDOWMENT TO ENSURE THAT NNF HAS THE RESOURCES NECESSARY TO SUPPORT ITS SCIENTIFIC, HUMANITARIAN, AND OTHER SOCIAL WELFARE GRANTMAKING.
Activities or mission (Part I)
NOVO NORDISK FONDEN (NNF) IS AN ORGANIZATION RECOGNIZED BY THE IRS AS DESCRIBED IN SECTION 501(C)(4) THAT AWARDS GRANTS TO SUPPORT SCIENTIFIC, HUMANITARIAN AND SOCIAL CAUSES. NOVO HOLDINGS A/S (NH) HOLDS AND MANAGES NNF'S ENDOWMENT TO ENSURE THAT NNF HAS THE RESOURCES NECESSARY TO SUPPORT ITS SCIENTIFIC, HUMANITARIAN, AND OTHER SOCIAL WELFARE GRANTMAKING.
-
NOVO HOLDINGS A/S (NH) MANAGES NNF'S ENDOWMENT WITH THE AIM OF GENERATING ATTRACTIVE LONG-TERM RETURNS IN ORDER TO ENSURE THAT NNF HAS THE RESOURCES NECESSARY TO SUPPORT ITS SCIENTIFIC, HUMANITARIAN, AND OTHER SOCIAL WELFARE GRANTMAKING PROGRAMS, THUS IMPROVING PEOPLE'S HEALTH AND THE SUSTAINABILITY OF SOCIETY AND THE PLANET.
Expenses $106,954,414
As filed on the 2024 return.
Officers and directors · 2024
As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.
-
Lars Rebien SorensenLARS REBIEN SORENSEN
CHAIR
- Total calculated
- $672,365
- From this org
- $298,063
- From related orgs
- $374,302
- Other
- $0
- Hours/week
- 1 + 1 related
Schedule J breakdown matched by us
- Base
- $260,200 + $271,481 related
- Bonus
- $0
- Other
- $37,863 + $102,821 related
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $298,063 + $374,302 related
-
Steen RiisgaardSTEEN RIISGAARD
VICE CHAIR
- Total calculated
- $413,317
- From this org
- $189,693
- From related orgs
- $223,624
- Other
- $0
- Hours/week
- 1 + 1 related
Schedule J breakdown matched by us
- Base
- $173,467 + $60,329 related
- Bonus
- $0
- Other
- $16,226 + $163,295 related
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $189,693 + $223,624 related
-
Britt Meelby JensenBRITT MEELBY JENSEN
DIRECTOR
- Total calculated
- $175,479
- From this org
- $175,479
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
Schedule J breakdown matched by us
- Base
- $159,253
- Bonus
- $0
- Other
- $16,226
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $175,479
-
Henrik PoulsenHENRIK POULSEN
DIRECTOR
- Total calculated
- $102,959
- From this org
- $102,959
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
-
Jeppe ChristiansenJEPPE CHRISTIANSEN
DIRECTOR
- Total calculated
- $102,959
- From this org
- $102,959
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
-
Jean-Luc ButelJEAN-LUC BUTEL
DIRECTOR
- Total calculated
- $213,342
- From this org
- $213,342
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
Schedule J breakdown matched by us
- Base
- $159,253
- Bonus
- $0
- Other
- $54,089
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $213,342
-
Francis Michael Cyprian CussFRANCIS MICHAEL CYPRIAN CUSS
DIRECTOR
- Total calculated
- $135,413
- From this org
- $135,413
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
-
Viviane MongesVIVIANE MONGES
DIRECTOR
- Total calculated
- $135,461
- From this org
- $135,461
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
-
Susanne Antonie SchaffertSUSANNE ANTONIE SCHAFFERT
DIRECTOR
- Total calculated
- $191,706
- From this org
- $191,706
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
Schedule J breakdown matched by us
- Base
- $159,253
- Bonus
- $0
- Other
- $32,453
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $191,706
-
Kasim KutayKASIM KUTAY
CEO
- Total calculated
- $7,125,236
- From this org
- $2,442,078
- From related orgs
- $0
- Other
- $4,683,158
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $1,984,388
- Bonus
- $435,689
- Other
- $22,001
- Deferred
- $4,683,158
- Nontaxable benefits
- $0
- Filer's total
- $7,125,236
-
Nigel Kevin GovettNIGEL KEVIN GOVETT
CFO
- Total calculated
- $626,661
- From this org
- $498,174
- From related orgs
- $0
- Other
- $128,487
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $349,237
- Bonus
- $135,757
- Other
- $13,180
- Deferred
- $128,487
- Nontaxable benefits
- $0
- Filer's total
- $626,661
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.
Filings
-
2024
- Revenue
- $3,542,774,981
- Expenses
- $277,559,658
- Contributions
- $0
- Grants paid
- $0
-
2023
- Revenue
- $2,825,772,201
- Expenses
- $286,822,414
- Contributions
- $0
- Grants paid
- $0
The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.
Grants made
No itemized grants to organizations. Schedule I is filed only by organizations that granted more than $5,000 to a recipient, so most filers have none.
Grants received
No itemized grant names this organization as a recipient. Only grants over $5,000 are itemized, and only by filers of the full Form 990.
Related organizations
From Schedule R Part II, where a filer lists the tax-exempt organizations it is related to by control. It does not record shared board members or money.
Declared on its 2024 return
-
501(C)(4) · GRANTMAKING · DA
Declared as related by
-
On its 2024 return as a controlled entity
Taxable family
From Schedule R Parts I, III and IV: entities that legally are the filer, and taxable partnerships, corporations and trusts it is related to. These record ownership and control, not shared board members or money.
Related partnerships on its 2024 return
-
NH KRONOS ULTIMATE HOLDINGS LP
RELATED · LIFE SCIENCES · MA · 89.41% owned · share of assets $493,184,619 · general or managing partner
-
NH KRONOS HOLDINGS LP
LIFE SCIENCES · MA
-
MAIA AGGREGATOR LP
LIFE SCIENCES · MA
-
NOVO MAIA LP
RELATED · LIFE SCIENCES · MA · 75.4% owned · share of income $15,737,261 · share of assets $336,601,516 · general or managing partner
-
NOVO VENTURES 1 PS
RELATED · LIFE SCIENCES · DA · 100% owned · share of income $37,169,023 · share of assets $299,303,984 · general or managing partner
-
NOVO CAPITAL INVESTORS PS
RELATED · LIFE SCIENCES · DA · 100% owned · share of income $91,992,314 · share of assets $5,995,739 · general or managing partner
-
NOVO NORDISK PHARMACEUTICAL INDUSTRIES LP
LIFE SCIENCES · NC
-
NOVO RHEA AGGREGATOR LP
LIFE SCIENCES · MA
-
RHEA ACQUISITION HOLDINGS LP
LIFE SCIENCES · MA
-
RHEA INTERMEDIATE LP
LIFE SCIENCES · MA
-
EJENDOMSSELSKABET NOVO HOLDINGS PS
RELATED · LIFE SCIENCES · DA · 100% owned · share of income -$233,776 · share of assets $16,377,032 · general or managing partner
-
QUANTUM FOUNDRY PS
LIFE SCIENCES · DA
-
NOVO NORDISK FOUNDATION CELLERATOR PS
LIFE SCIENCES · DA
-
NVAC PS
LIFE SCIENCES · DA
-
NH AIFM PS (NOVO INVEST F2PS)
RELATED · LIFE SCIENCES · DA · 100% owned · share of income -$1,712,421 · share of assets $113,863 · general or managing partner
-
NOVO HOLDINGS BUSINESS & PEOPLE SUPPORT PS
RELATED · LIFE SCIENCES · DA · 100% owned · share of income -$68,595 · share of assets $23,861 · general or managing partner
-
NOVO HOLDINGS DK INVESTMENT ADVISOR PS
RELATED · LIFE SCIENCES · DA · 100% owned · share of income -$4,931 · share of assets $59,583 · general or managing partner
-
CREEK HOLDINGS LP
RELATED · LIFE SCIENCES · MA · 98% owned · share of income -$58,609,241 · share of assets $2,647,613,058 · general or managing partner
-
CREEK FEEDER LP
LIFE SCIENCES · MA
Related corporations and trusts on its 2024 return
-
NOVO NORDISK AS
C · LIFE SCIENCES · DA · 77.3% owned · share of income $18,068,595,461 · share of assets $58,784,343,822 · controlled entity
-
ALDAPH SPA
C · LIFE SCIENCES · AG · controlled entity
-
BEIJING NOVO NORDISK PHARMACEUTICALS SCIENCE AND TECHNOLOGY
C · LIFE SCIENCES · CH · controlled entity
-
CORVIDIA THERAPEUTICS INC
C · LIFE SCIENCES · MA · controlled entity
-
DICERNA PHARMACEUTICALS INC
C · LIFE SCIENCES · KY · controlled entity
-
EMISPHERE TECHNOLOGIES INC
C · LIFE SCIENCES · NJ · controlled entity
-
FORMA THERAPEUTICS INC
C · LIFE SCIENCES · DA · controlled entity
-
NN PANAMA
C · LIFE SCIENCES · PM · controlled entity
-
NNE PHARMAPLAN AS
C · LIFE SCIENCES · DA · controlled entity
-
NNE PHARMAPLAN AS - UNITED STATES PE
C · LIFE SCIENCES · NC · controlled entity
-
NNE PHARMAPLAN AB
C · LIFE SCIENCES · SW · controlled entity
-
NNE PHARMAPLAN INC
C · LIFE SCIENCES · NC · controlled entity
-
NNE PHARMAPLAN INDIA LIMITED
C · LIFE SCIENCES · IN · controlled entity
-
NNE PHARMAPLAN OOO
C · LIFE SCIENCES · RS · controlled entity
-
NOVO INVESTMENTS PTE LIMITED
C · LIFE SCIENCES · SN · controlled entity
-
NOVO NORDISK (CHINA) PHARMACEUTICALS CO LTD
C · LIFE SCIENCES · CH · controlled entity
-
NOVO NORDISK (PTY) LIMITED
C · LIFE SCIENCES · SF · controlled entity
-
NOVO NORDISK (SHANGHAI) HOLDING CO LTD
C · LIFE SCIENCES · CH · controlled entity
-
NOVO NORDISK (SHANGHAI) PHARMA TRADING CO LTD
C · LIFE SCIENCES · CH · controlled entity
-
NOVO NORDISK BV
C · LIFE SCIENCES · NL · controlled entity
-
NOVO NORDISK BIOPHARM LIMITED
C · LIFE SCIENCES · DA · controlled entity
-
NOVO NORDISK CANADA INC
C · LIFE SCIENCES · CA · controlled entity
-
NOVO NORDISK COLOMBIA SAS
C · LIFE SCIENCES · CO · controlled entity
-
NOVO NORDISK COMERCIO PRODUTOS FARMACEUTICOS LDA
C · LIFE SCIENCES · PO · controlled entity
-
NOVO NORDISK DOO
C · LIFE SCIENCES · SI · controlled entity
The first 25 as filed. The return lists the rest.
Other IRS files
Auto-Revocation List
Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.
Publication 78
Not present in the most recent drop.
These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.
What this page reflects
The registration facts above come from the IRS Business Master File published 9 November 2026 and read 9 November 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.